Post-Dural Puncture Headache Clinical Trial
Official title:
Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache: A Randomized Clinical Trial
Verified date | February 2020 |
Source | Damanhour Teaching Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objectives: To compare the safety and efficacy of oral theophylline versus oral sumatriptan in the treatment of post-dural puncture headache (PDPH). Background: PDPH is the most frequent complication of procedures associated with dural puncture for spinal anesthesia or following accidental dural puncture during epidural anesthesia. Since invasive treatments have known complications, pharmacologic management may be preferable. Patients and Methods: This was a prospective, randomized, double-blind, phase four clinical trial; carried out on 60 patients presented with PDPH at our hospital. Patients were randomly allocated into two equal groups (30 patients each); group T, received oral theophylline, and group S, received oral sumatriptan.
Status | Completed |
Enrollment | 60 |
Est. completion date | May 15, 2021 |
Est. primary completion date | May 15, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 50 Years |
Eligibility | Inclusion Criteria: - Patients with NPRS score of = 5 - American Society of Anesthesiologists (ASA) physical status = II - Age from 21 to 50 years Exclusion Criteria: - Patients with NPRS score < 5 - ASA physical status > II - Age < 21 years or > 50 years - Pregnant women - History of; Chronic headache, Cluster headache, Migraine - History of; Convulsions, Cerebrovascular accident, Previous neurological diseases - History of peripheral vascular disease (ischemic colitis) - Signs of meningismus - Dysrhythmia - Hypertension - Ischemic heart disease - Hyperthyroidism - Liver or Renal impairment - Use of selective serotonin reuptake inhibitors (SSRIs) - Use of ergotamine derivatives in the past 24 hours - Use of monoamine oxidase inhibitors (MAOIs) in the last two weeks - Use of any kind of opiates - Allergy to the study medications - Any contraindication of oral intake |
Country | Name | City | State |
---|---|---|---|
Egypt | Damanhour Teaching Hospital | Damanhur | El-Beheira |
Lead Sponsor | Collaborator |
---|---|
Damanhour Teaching Hospital |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Median and Range of Numeric Pain Rating Scale (NPRS) score [(median (range)] | NPRS measures the severity of PDPH, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (before, 2h, 6h, 12h, 18h, 24h, then every 12h till 48h) | 48 hours after initiation of treatment | |
Primary | Mean and Standard deviation of Numeric Pain Rating Scale (NPRS) score (mean±SD) | NPRS measures the severity of PDPH, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (before, 2h, 6h, 12h, 18h, 24h, then every 12h till 48h) | 48 hours after initiation of treatment | |
Secondary | Mean and Standard deviation of PDPH duration (hours) (mean±SD) | Time from PDPH onset till NPRS score = 3 | 48 hours after initiation of treatment | |
Secondary | Mean and Standard deviation of Length of hospital stay (days) (mean±SD) | Time from hospital admission till discharge | 48 hours after initiation of treatment | |
Secondary | Number of participants and Rate of Treatment-related side effects | Number of participants and Rate of: Palpitation, Dizziness, Gastric irritation, Nausea/Vomiting, Diarrhea, Warm sensations in the body, Tingling sensation, and Tightness in the chest, throat, neck, or jaws. | 48 hours after initiation of treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04091321 -
Association Between Chronic Headache and Back Pain With Childbirth
|
||
Recruiting |
NCT05202574 -
Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section
|
Phase 2 | |
Terminated |
NCT02813655 -
Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)
|
Phase 2 | |
Completed |
NCT02522013 -
Aminophylline for Patients With Post-Dural Puncture Headache
|
Phase 3 | |
Recruiting |
NCT06444737 -
Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia
|
N/A | |
Completed |
NCT05301387 -
The Effect of Ganglion Sphenopalatine Block (GSP-block) Follow-Up
|
||
Recruiting |
NCT05637645 -
Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section
|
N/A | |
Recruiting |
NCT05116930 -
Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture
|
Phase 2 | |
Terminated |
NCT03430531 -
Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
|
Phase 2 | |
Completed |
NCT04401878 -
SGB in Management of Patients With PDPH Using TCD
|
N/A | |
Completed |
NCT04327726 -
Effectiveness of Nebulized Dexmedetomidine for Treatment of Obstetric Post-Dural Puncture Headache
|
N/A | |
Completed |
NCT03475784 -
Two Fluid Strategies for Prevention of Post-dural Puncture Headache
|
Phase 3 | |
Not yet recruiting |
NCT06272916 -
Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.
|
||
Terminated |
NCT02827058 -
The Influence of Needle Diameter on Post Dural Puncture Headache
|
N/A | |
Completed |
NCT05262933 -
Effects of Preoperative Coffee Consumption in Cesarean Sections Under Spinal Anesthesia
|
||
Completed |
NCT04793490 -
Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients
|
N/A | |
Recruiting |
NCT05888324 -
Factors Associated With the Onset of Chronic Headaches in Patients Who Received a Blood Patch in Post Partum
|
||
Completed |
NCT00370604 -
Effect of Small Versus Large Epidural Needles on Postdural Puncture Headache Study
|
N/A | |
Completed |
NCT04844229 -
Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache
|
N/A | |
Withdrawn |
NCT03560349 -
RCT of SPG Blocks for Post-dural Headache
|
Phase 2 |